Total Tumor Load to assist in the decision for additional axillary surgery in the positive sentinel node breast cancer patients

Lyman, 2005, American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer, J. Clin. Oncol., 23, 7703, 10.1200/JCO.2005.08.001 Veronesi, 2006, Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study, Lancet Oncol., 7, 983, 10.1016/S1470-2045(06)70947-0 Krag, 2010, Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial, Lancet Oncol., 11, 927, 10.1016/S1470-2045(10)70207-2 Mansel, 2006, Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial, JNCI, J. Natl. Cancer Inst., 98, 599, 10.1093/jnci/djj158 Galimberti, 2012, Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer?, Breast Cancer Res. Treat., 131, 819, 10.1007/s10549-011-1486-2 Viale, 2005, Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy, Ann. Surg., 241, 10.1097/01.sla.0000150255.30665.52 Galimberti, 2013, Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial, Lancet Oncol., 14, 297, 10.1016/S1470-2045(13)70035-4 Ivens, 1992, Assessment of morbidity from complete axillary dissection, Br. J. Cancer, 66, 136, 10.1038/bjc.1992.230 Peintinger, 2003, Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients, Br. J. Cancer, 89, 648, 10.1038/sj.bjc.6601150 Fougo, 2009, Predictive factors for non-sentinel lymph node involvement in breast cancer patients with a positive sentinel node: should we consider sentinel node-related factors?, Clin. Transl. Oncol., 11, 165, 10.1007/S12094-009-0333-y Fougo, 2020, Sentinel node total tumour load as a predictive factor for non-sentinel node status in early breast cancer patients – the porttle study, 108 Giuliano, 2017, Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial, JAMA, J. Am. Med. Assoc., 318, 918, 10.1001/jama.2017.11470 Jagsi, 2014 Latosinsky, 2012, Axillary dissection versus no axillary dissection in women with invasive breast cancer and sentinel node metastasis, Can. J. Surg., 55, 66, 10.1503/cjs.036011 Tsujimoto, 2007, One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients, Clin. Cancer Res., 13, 4807, 10.1158/1078-0432.CCR-06-2512 Espinosa-Bravo, 2013, Prediction of non-sentinel lymph node metastasis in early breast cancer by assessing total tumoral load in the sentinel lymph node by molecular assay, Eur. J. Surg. Oncol., 39, 766, 10.1016/j.ejso.2013.03.011 Rubio, 2014, Nomogram including the total tumoral load in the sentinel nodes assessed by one-step nucleic acid amplification as a new factor for predicting nonsentinel lymph node metastasis in breast cancer patients, Breast Cancer Res. Treat., 147, 371, 10.1007/s10549-014-3108-2 Goonawardena, 2020, Use of indocyanine green fluorescence compared to radioisotope for sentinel lymph node biopsy in early-stage breast cancer: systematic review and meta-analysis, Am. J. Surg., 220, 665, 10.1016/j.amjsurg.2020.02.001 Kern, 1999, Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye, J. Am. Coll. Surg., 189, 10.1016/S1072-7515(99)00200-8 Borgstein, 2000, Functional lymphatic anatomy for sentinel node biopsy in breast cancer: echoes from the past and the periareolar blue method, Ann. Surg., 232, 10.1097/00000658-200007000-00012 Berg, 1955, The significance of axillary node levels in the study of breast carcinoma, Cancer, 8, 776, 10.1002/1097-0142(1955)8:4<776::AID-CNCR2820080421>3.0.CO;2-B Goldhirsch, 2013, Personalizing the treatment of women with early breast cancer: highlights of the st gallen international Expert consensus on the primary therapy of early breast cancer 2013, Ann. Oncol., 24, 2206, 10.1093/annonc/mdt303 Mandrekar, 2010, Receiver operating characteristic curve in diagnostic test assessment, J. Thorac. Oncol., 5, 1315, 10.1097/JTO.0b013e3181ec173d Fougo, 2011, Validating the MSKCC nomogram and a clinical decision rule in the prediction of non-sentinel node metastases in a Portuguese population of breast cancer patients, Breast, 20, 134, 10.1016/j.breast.2010.10.009 Donker, 2014, Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial, Lancet Oncol., 15, 1303, 10.1016/S1470-2045(14)70460-7 Leonard, 2012, Axillary lymph node dose with tangential whole breast radiation in the prone versus supine position: a dosimetric study, Radiat. Oncol., 7, 72, 10.1186/1748-717X-7-72 Alonso-Basanta, 2009, Coverage of axillary lymph nodes in supine vs. Prone breast radiotherapy, Int. J. Radiat. Oncol. Biol. Phys., 73, 745, 10.1016/j.ijrobp.2008.04.040 Cardoso, 2019, Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†, Ann. Oncol., 30, 1194, 10.1093/annonc/mdz173 Zhang, 2013, Metastasis dormancy in estrogen receptor-positive breast cancer, Clin. Cancer Res., 19, 6389, 10.1158/1078-0432.CCR-13-0838 Ohi, 2012, Whole sentinel lymph node analysis by a molecular assay predicts axillary node status in breast cancer, Br. J. Cancer, 107, 1239, 10.1038/bjc.2012.387 Nabais, 2017, Total tumor load assessed by one-step nucleic acid amplification assay as an intraoperative predictor for non-sentinel lymph node metastasis in breast cancer, Breast, 32, 33, 10.1016/j.breast.2016.12.011 van Roozendaal, 2017, Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08), BMC Cancer, 17, 459, 10.1186/s12885-017-3443-x Kim, 2020, Korean Breast Cancer Society. Omission of axillary lymph node dissection in patients who underwent total mastectomy with 1 or 2 metastatic lymph nodes, Ann. Surg. Treat Res., 98, 283, 10.4174/astr.2020.98.6.283